Articles by Jill Wechsler - Pharmaceutical Executive

ADVERTISEMENT

Articles by Jill Wechsler

Foreign Affairs

Sep 1, 2008

FDA missteps and global outsourcing are drawing Congressional scrutiny and prompting new oversight approaches

Can Sentinel Save Drug Development?

Aug 1, 2008

FDA's new sentinel system shows the pendulum swing toward safety won't swing back anytime soon

Smooth Sailing for Orphans

Rare disease treatments are riding high as patient advocates, pharma companies, and government officials celebrate the ODA's 25th anniversary
Jul 1, 2008

Rare disease treatments are riding high as patient adcovates, pharma companies, and government officials celebrate the ODA's 25th anniversary

Candidates Target Pharma

Jun 1, 2008

US presidential hopefuls look to comparative effectiveness analysis to address price and access issues

Dial FDA: Marketers Face Added DTC Requirements

May 21, 2008

Feds consider adding an 800 number to television ads for adverse event reporting. Does this shine light on DTC ads while pushing public health goals? Industry is mum on the topic

FDA to Congress: "Show Us The Money"

May 1, 2008

FDA is being pressured to get its act together. The agency says it needs more money and more people to get approvals out the door

Supply Chains Without Borders

Apr 1, 2008

International outsourcing carries risks for marketers and regulatory challenges for FDA

Open Season on FDA

Congress is firing plenty of ammunition at pharma companies—and the regulators
Mar 1, 2008

Congress is firing plenty of ammunition at pharma companies—and the regulators

Funding Follies at FDA

Congress blocks DTC user fees, Reagan-Udall, and field force reforms while granting a slight
Feb 1, 2008

Congress blocked DTC user fees, Reagan-Udall, field force reforms while slightly bumping FDA's budget

ADVERTISEMENT

Click here